References
Davidson C (1954) pallido-pyramidal disease. J Neuropathol Exp Neurol 13:50–59
Hampshire DJ, Roberts E, Crow Y, Bond J, Mubaidin A, Wriekat AL, Al-Din A, Woods CG (2001) Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet 38:680–682
Tranchant C, Boulay C, Warter JM (1991) Pallido-pyramidal syndrome: an unrecognized entity. Rev Neurol (Paris) 147:308–310
Horowitz G, Greenberg J (1975) Pallido-pyramidal syndrome treated with levodopa. J Neurol Neurosurg Psychiatry 38:238–240
Remy P, Hosseini H, Degos JD, Samson Y, Agid Y, Warter JM, et al. (1995) Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography. Ann Neurol 38:954–956
Pradat PF, Dupel-Pottier C, Lacomblez L, Salachas F, Meininger V, Lacomblez L, Spelle L, Bonnaud I, Ribeiro MJ, Remy P, Samson Y (2001) Case report of pallido-pyramidal disease with supplementary motor area involvement. Mov Disord 16:762–764
Nisipeanu P, Kuritzki A, Korezyn AD (1994) Familial levodopa responsive parkinsonian-pyramidal syndrome. Mov Disord 9:673–675
Kalita J, Mishra UK, Das BK (2003) Sporadic variety of pallido-pyramidal syndrome. Neurology India 51:383–384
Esmaeli-Gutstein B, Nahmias C, Thompson M, Kazdan M, Harvey J (1999) Positron emission tomography in patients with benign essential Blepharospasm. Plast Reconstr Surg 15:23–27
Kerrison JB, Lancaster JL, Zamarripa FE, Richardson LA, Morrison JC, Holck DE, Andreason KW, Blaydon SM, Fox PT (2003) Positron emission tomography scanning in essential blepharospasm. Am J Ophthalmol 136(5):846–852
Nisipeanu P, Korezyn AD (1999) The parkinsonian pyramidal syndrome. In: Joseph AB, Young R (eds) Movement disorder in neurology and neuropsychiatry. Blackwell Science.Malden, 2nd edition, pp 247–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srivastava, T., Goyal, V., Singh, S. et al. Pallido-pyramidal syndrome with blepharospasm and good response to levodopa. J Neurol 252, 1537–1538 (2005). https://doi.org/10.1007/s00415-005-0852-6
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0852-6